Total Visits

Views
A Molecular and Preclinical Comparison of the PD-1 targeted T cell Checkpoint Inhibitors Nivolumab and Pembrolizumab229

Total Visits Per Month

July 2020August 2020September 2020October 2020November 2020December 2020January 2021
A Molecular and Preclinical Comparison of the PD-1 targeted T cell Checkpoint Inhibitors Nivolumab and Pembrolizumab2110612

File Downloads

Views
Fessas_et_al-2017-Seminars_in_Oncology-VoR.pdf131
Fessas_Lee_Ikemizu_Janowitz_SeminarsOnc_Nivo_Pembro_2017.docx1

Top country views

Views
United States83
France24
Israel24
Germany19
China12
Japan12
United Kingdom11
Turkey5
AP2
Australia2

Top cities views

Views
Ashburn24
Rishon Le Zion19
Fairfield16
Princeton12
Tokyo8
Cambridge5
Istanbul5
Boardman4
Narita4
Beijing3